Design, synthesis and molecular docking studies of benzothiazole derivatives as anti microbial agents

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 2, 2013, Pages 101-106

  Parvathy, N G ^a   Prathap, Manju ^a   Mukesh, M ^a   Thomas, Leena ^a  

^a NONE

Author keywords

Antimicrobial activity; Benzothiazole moiety, 1, 3, 4 oxadiazole; Molecular docking; Schiff bases

Indexed keywords

(2 (1,3 BENZOTHIAZOL 2 YLSULFANYL) N [(E) (2 CHLORO 6 HYDROXYPHENYL) METHYLIDENE] ACETOHYDRAZIDE; (2 (1,3 BENZOTHIAZOL 2 YLSULFANYL) N [(E) (2 HYDROXYPHENYL) METHYLIDENE] ACETOHYDRAZIDE); (2 (1,3 BENZOTHIAZOL 2 YLSULFANYL) N [(E) (4 HYDROXY 3 METHOXYPHENYL) METHYLIDENE] ACETOHYDRAZIDE); (2 (1,3 BENZOTHIAZOL 2 YLSULFANYL) N [(E) FURAN 2 METHYLIDENE]ACETOHYDRAZIDE; (2 (1,3 BENZOTHIAZOL 2 YLSULFANYL) N [(E) PHENYLMETHYLIDINE]ACETOHYDRAZIDE); (2 ({[5 (4 CHLOROPHENYL) 1,3,4 OXADIAZOL 2 YL]METHYL}SULFANYL) 1,3 BENZOTHIAZOLE); (2 {5 [(1,3 BENZOTHIAZOL 2 YLSULFANYL)METHYL] 1,3,4 OXADIAZOL 2 YL}BENZOICACID); (4 {5 [1,3 BENZOTHIAZOL 2YLSULFANYL)METHYL] 1,3,4 OXADIAZOL 2 YL}ANILINE); 2 (BENZO[D]THIAZOL 2 YLTHIO) ACETOHYDRAZIDE; 2 (BENZOTHIAZOLYLTHIO) ACETATE; ANTIINFECTIVE AGENT; BENZOTHIAZOLE DERIVATIVE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; OXADIAZOLE DERIVATIVE; PROTEIN N MYRISTOYLTRANSFERASE; SCHIFF BASE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CHEMICAL REACTION; COMPUTER MODEL; CONTROLLED STUDY; DRUG DESIGN; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; SPECTROSCOPY; STAPHYLOCOCCUS AUREUS;

EID: 84875951533     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Gilchrist TE: Heterocyclic Chemistry. 3. Longman; 1992.
2. Chaudhary P Recent advances in pharmacological activity of benzothiazole derivatives. International Journal of current pharmaceutical research 2010; 2(2): 170-176.
3. Yadav SK, Malipatil SM, Yadav SK Synthesis and biological evaluation of benzothiazole derivatives. IJDDHR 2010; 1(1): 42-43.
4. Nagaraj. 1, 3, 4 Oxadiazole: A potent drug candidate with various pharmacological activities. International Journal of Pharmacy and Pharmaceutical Sciences 2011; 3: 9-15.
5. Niazi S. Study of influence of linkers and substitutions on antimicrobial activity of some Schiff bases. Ijpps 2010; Vol 2: 108-112.
6. Hosam. A Saad. Microwave assisted synthesis of some new fused 1,2,4 triazines bearing thiophene moieties with expected pharmacological activity. Molecules 2011; 16:4937-4957.
7. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and application. Nature reviews. Drug discovery 2003; 3(11):935-949.
8. Levi SB, Drug Resistance: The New Apocalypse Trends. Microbiol. 1994; 2; 341-425.
9. Hemlata Kaur, Sunil Kumar, Indu Singh, K.K. Saxena, Ashok Kumar. Synthesis, characterization and biological activity of various substituted benzothiazole derivatives. Digest Journal of Nanosciences and Biostructures 2010; 5(1): 67-76.
10. Hamouly WS, Amin KM, Assaly SAEl, Meguid EAA: Synthesis and antitumor activity of some new 1,3,4-oxadiazole, pyrazole and pyrazolo[3,4-d]pyrimidine derivatives attached to 4-benzothiazol-2-yl phenyl moiety. Der Pharma Chemica 2011; 3 (6): 282-292.
11. K. G. Desai, J.P. Raval and K.R. Desai: Neat Reaction Technology for the Synthesis of 4-Oxo-thiazolidines Derived from 2-SH-Benzothiazole and Antimicrobial Screening of Some Synthesized 4-Thiazolidinones. Journal of the Iranian Chemical Society, September 2006; 3 (3): 233-241.